Subtype
Benign Skin Epithelial Neoplasm
CI-CAN-00000546Explore in graph →
Non-malignant10 active trials
- NCIt
- C7341
Loading cancer entity…
Subtype
CI-CAN-00000546Explore in graph →
Clinical trials
60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05889845 | Candin for the Treatment of Common Warts | completed | Phase 3 | 330 | Nielsen BioSciences, Inc.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03812510 | Safety Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 426 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Nov 23, 2020 | clinicaltrials |
| NCT03691831 |
| A Study of A-101 Topical Solution for the Treatment of Common Warts |
| completed |
| Phase 3 |
| 502 |
| Aclaris Therapeutics, Inc.INDUSTRY |
| 1 |
| Oct 27, 2020 |
| clinicaltrials |
| NCT03687372 | Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 503 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Oct 5, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Sep 5, 2025source: clinicaltrials